Ubigene Highlights In Vivo CRISPR Screening in Translational Research
NEW YORK, January 2026 – Ubigene, a global biotechnology innovator specializing in precision gene editing solutions, is highlighting the growing importance of in vivo CRISPR screening in advancing translational research and target discovery. The focus reflects broader industry efforts to better understand gene function within biologically relevant systems as gene editing technologies continue to evolve….
